
|Articles|November 1, 1997
The American Journal of Managed Care
- November 1997
- Volume 3
- Issue 11
When Is a Cost-Effectiveness Claim Valid? How Much Should the FDA Care?
Advertisement
Articles in this issue
over 28 years ago
Healthcare Utilization Among Women with Eating Disordered Behaviorover 28 years ago
Postpartum Depressionover 28 years ago
Pharmaceutical Considerations of Common Herbal Medicineover 28 years ago
Treatment Patterns for Heart Failure in a Primary Care Environmentover 28 years ago
Enhancement of Compliance Among Patients with HypertensionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets
2
Asundexian Cuts Recurrent Stroke Risk Without More Bleeding: Mukul Sharma, MD, MSc
3
Faricimab Safe, Effective for Use in Treating nAMD in Treatment-Naive Eyes
4
Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care
5

















